Zacks reiterated their neutral rating on shares of Health Management Associates (NYSE:HMA) in a research note released on Friday morning, Analyst Ratings Net reports. They currently have a $14.00 target price on the stock.
Zacks’ analyst wrote, “Health Management posted a loss of $0.01 and missed the Zacks Consensus Estimate by $0.17 per share. Its revenues of $1,421.2 million also missed the mark in the quarter. However, investors are optimistic about its merger with the Community Health Systems. The company has indicated its willingness to deploy free cash flow for acquisitions, which carries certain risks. Sizeable debt remains on the balance sheet. The company continues to emphasize its three long-standing initiatives, namely Emergency Room operations, physician recruitment and market development, which have facilitated admissions. As such, we reiterate our Neutral recommendation and set a target of $14.00.”
Zacks has also updated their ratings on a number of other healthcare stocks in the last week. The firm reiterated its neutral rating on shares of Patterson Cos. Inc.. They have a $43.00 price target on that stock. Also, Zacks upgraded shares of BioScrip Inc. from an underperform rating to a neutral rating. Zacks now has a $6.25 price target on that stock.
Health Management Associates (NYSE:HMA) traded up 0.08% during mid-day trading on Friday, hitting $13.10. The stock had a trading volume of 2,104,633 shares. Health Management Associates has a 52 week low of $7.25 and a 52 week high of $17.28. The stock has a 50-day moving average of $12.88 and a 200-day moving average of $13.45. The company’s market cap is $3.465 billion.
Health Management Associates (NYSE:HMA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.01) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.16 by $0.17. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same quarter in the prior year, the company posted $0.18 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. Analysts expect that Health Management Associates will post $0.48 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on HMA. Analysts at Barclays cut their price target on shares of Health Management Associates from $15.00 to $14.00 in a research note to investors on Friday, November 15th. Separately, analysts at FBR & Co. initiated coverage on shares of Health Management Associates in a research note to investors on Friday, November 8th. They set a market perform rating on the stock. Finally, analysts at FBR Capital Markets initiated coverage on shares of Health Management Associates in a research note to investors on Friday, November 8th. They set a market perform rating on the stock. One research analyst has rated the stock with a sell rating, eighteen have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of Hold and an average price target of $13.85.
Health Management Associates, Inc by and through its subsidiaries operates general acute care hospitals and other health care facilities in non-urban communities.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.